Quarterly report pursuant to Section 13 or 15(d)

Other Balance Sheet Items (Tables)

v3.24.1.u1
Other Balance Sheet Items (Tables)
 6 Months Ended
Mar. 31, 2024
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]  
Schedule of Cash and Cash Equivalents
Table 10.1: Details of Cash and Cash Equivalents and Restricted Cash
March 31, 2024 September 30, 2023
(in thousands)
Cash and cash equivalents $ 77,370  $ 65,405 
Restricted cash 40,970  56,686 
Cash, cash equivalents, and restricted cash $ 118,340  $ 122,091 
Schedule of Restrictions on Cash and Cash Equivalents
Table 10.1: Details of Cash and Cash Equivalents and Restricted Cash
March 31, 2024 September 30, 2023
(in thousands)
Cash and cash equivalents $ 77,370  $ 65,405 
Restricted cash 40,970  56,686 
Cash, cash equivalents, and restricted cash $ 118,340  $ 122,091 
Schedule of Supplementary Cash Flow Information
Table 10.2: Supplemental Disclosures of Cash Flow Information
For the Six Months Ended
March 31, 2024 March 31, 2023
(in thousands)
Interest payments $ 39,946  $ 19,262 
Income tax payments $ 43,794  $ 31,926 
Schedule of Details of Accounts Receivable
Table 10.3: Details of Accounts Receivable, Net
March 31, 2024 September 30, 2023
(in thousands)
Billed and billable receivables $ 776,877  $ 692,707 
Unbilled receivables 150,956  137,885 
Allowance for credit losses (11,829) (3,719)
Accounts receivable, net $ 916,004  $ 826,873